Home >>Webcast>>Fetomaternal Medicine

Thursday, November 12, 2009

18:30-20:00

Welcome Reception

 

Friday, November 13, 2009

  

08:30-10:00	Keynote Lectures Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future
Capsule	What does the future hold for our main subdisciplines?
Chairpersons	Z. Ben-Rafael, Israel V. Gomel, Canada G.C. Di Renzo, Italy
08:30-09:00	Fetomaternal Medicine: Intrauterine stem cell transplantation T-H. Bui, Sweden
09:00-09:30	Gynecology: Surgical approach for endometriosis, do we have limits? F. Nezhat, USA
09:30-10:00	Infertility & ART: The Future of In Vitro Maturation (IVM) R.Fadini, Italy
10:00-10:30	Coffee break
10:30-12:30	Prevention of Preterm Delivery
Capsule	Preterm delivery continues to be a major issue in perinatal medicine, yet no effective prevention is available
Chairperson	G. Sylvestre, USA
10:30-11:00	Should we repeat atosiban tocolysis as frequesntly as required? I. Blickstein, Israel
11:00-11:30	Progesterone and pregnancy:facts and fictions G.C. Di Renzo, Italy
11:30-12:00	How should a short cervix be managed? I. Wolman, Israel
12:00-12:30	Can nutrition reduce the risk of preterm delivery? P. Lam, China
12:30-13:30	Lunch break
13:30-15:30	Emergency Situation in Perinatology
Capsule	Life-threatening situation in obstetrics should be identified and treated early
Chairpersons	I. Blickstein, Israel R.B. Kalish, USA
13:30-14:00	Uterine atony: What are the most effective steps before hysterectomy? G.H. Leonard, USA
14:00-14:30	Thrombophilia and pregnancy complications: Requiem? D. Blickstein, Israel
14:30-15:00	Can we save patients with amniotic fluid embolism? G.H. Leonard, USA
15:00-15:30	Optimal management of placenta accreta G. Sylvestre, USA
15:30-16:00	Coffee break
16:00-18:00	Hot Controversies - Expert Opinion on: Intrapartum Surveillance
Capsule	Is it possible to minimize the risk of intrapartum asphyxia?
Chairpersons	G.C. Di Renzo, Italy A. Antsaklis, Greece
Discussants	X. Carbonell-Estrany, Spain M. Carrapato, Portugal I. Blickstein, Israel R.B. Kalish, USA H. Divakar, India
	Questions（click here） > How do we assess 'fetal reserve'? > What is the evidence for intermittent vs. continuous monitoring? > How do we assess acid-based status? > What are the new monitoring technologies? > Medico-legal implications > Early versus late cord clamping. Obstetrical and neonatal view > Problems in delivery room resuscitation of very-small-low-birth-weight infants > Autologous blood donation: What is its role in South East Asia obstetics and gynecology?
Saturday, November 14, 2009
08:30-10:00	Early Screening for Nuchal Thickness (NT)
Capsule	NT is a cornerstone in early detection of anomalies; however, confusion exists regarding the next step in increased NT
Chairpersons	X. Carbonell-Estrany, Spain G.H. Leonard, USA
08:30-09:30	Debate Proposition: Chorionic villus sampling (CVS) is the next step following increased NT T-H Bui, Sweden Opposition: CVS should be performed only if detailed screening for anomalies is negative Z. Weiner, Israel
09:30-10:00	Can we agree on the definition of Dandy-Walker syndrome in ultrasonography? Y. Zalel, Israel
10:00-10:30	Coffee break
10:30-12:30	Hot Controversies - Expert Opinion on: Ultrasound (US) Screening for Anomalies
Capsule	Screening for anomalies with US is widely used, however many parts of the examination remain controversial
Chairperson	T-H Bui, Sweden
Discussants	Z. Weiner, Israel G. Sylvestre, USA  Y. Zalel, Israel A. Antsaklis, Greece
	Questions Nasal bone: Fact or myth? Can "family album" assist in prenatal US screening? What can be gained by combining transvaginal screening (TVS) with transabdominal screening (TAS) in late (24 weeks) sonographic screening? Does intra-amniotic sludge predict preterm delivery? Can we agree on the definition of Dandy-Walker syndrome in ultrasonography? Early (14-16 weeks) or late (18-22 weeks) screening? Amniotic band syndrome: Fact or myth? Ultrasound: What is its reliability in the diagnosis of placenta accreta and vasa previa? Elective fetal reduction: In the early or late first trimester? Folic acid: Can it prevent other conditions or only NTD? And at what dose?
12:30-13:30	Lunch break
13:30-15:30	US Screening for Anomalies II
Capsule	Cardiac anomalies can affect 1:200 low-risk patients; however, current recommendations are that only high-risk cases be screened. Are these valid?
Chairpersons	X. Carbonell-Estrany, Spain R.B. Kalish, USA
13:30-14:30	Debate Proposition:  Guidelines usually recommend that an echocardiogram be performed in high-risk cases, and between 18 and 20 weeks Y. Zalel, Israel Opposition: An echocardiogram should be performed in all low-risk patients, and 99% can already be identified at 12-16 weeks! Z. Weiner, Israel
14:30-15:00	Screening by US in perinatal medicine A. Antsaklis, Greece
15:00-15:30	What are the traps and tricks in performing "four chamber views"?  Y. Zalel, Israel
15:30-16:00	Coffee break
16:00-18:00	Complications of Pregnancy: Pre-eclampsia
Capsule	Can we decrease mortality and morbidity through early diagnosis and treatment of pre-eclampsia?
Chairpersons	A. Antsaklis, Greece E. Schiff, Israel
16:00-16:30	Controversies regarding late offspring outcome of mothers with pre-eclampsia M. Carrapato, Portugal
16:30-17:00	Can we predict or prevent pre-eclampsia? E. Schiff, Israel
17:00-17:30	Can we manage pre-eclampsia effectively without knowing the pathophysiology? TBA
17:30-18:00	Angiogenic biomarkers for pre-eclampsia W.W. Sumpaico, Philippines
18:30-20:00	"Voices" Special Entertainmetn Lecture by Dr. C.O. (Skip) Granai, USA
Sunday, November 15, 2009
08:30-10:00	Complications of Pregnancy I
Capsule	The SEA perspectives on medical complications of pregnancy  Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
Chairperson	W.W. Sumpaico, Philippines G. Sylvestre, USA
08:30-08:52	Where have we gone wrong in obstetric sonography and prenatal diagnosis? C. Anandakumar, Singapore
08:52-09:14	How does gestational anemia affect Generation next? H. Divakar, India
09:14-09:36	How can we deal with gestational diabetes mellitus (GDM) in low-resource settings? U. Thanawala, India
09:36-10:00	Screening for thyroid dysfunction in pregnancy: The South Asian perspective W.W. Sumpaico, Philippines
10:00-10:30	Coffee break
10:30-12:30	Complications of Pregnancy II
Capsule	Recent studies claim that vaginal breech delivery is unsafe: Lack of experienced obstetricians supports the conclusion
Chairpersons	E. Schiff, Israel
10:30-11:15	Debate The Breech Debate: It is Proven Beyond any Doubt that Vaginal Breech Delivery is Unsafe Proposition: Vaginal breech delivery is unsafe! All term breeches should be delivered by elective Caesarean section G. Sylvestre, USA / R.B. Kalish, USA Opposition: Singleton vaginal breech delivery at term: Still a safe option I. Blickstein, China
11:15-11:45	External cephalic version in modern obstetrics: Risks vs. benefits? R.B. Kalish, USA
11:45-12:30	Debate Are Twins Really an Adverse Outcome in IVF? Yes: I. Blickstein, Israel No: N. Gleicher, USA